Articles
Volume 3 Supplement 1
23rd Congress of the International Association for Breast Cancer Research
- Meeting abstracts
- from 23rd Congress of the International Association for Breast Cancer Research
- Düsseldorf, Germany
- 13-16 June 2001
|
The NJ Agnantis, SA Kamina, PS Zagorianakou, A Demou, A Katsaraki, P Kanavaros, M Bai Breast Cancer Res 2001, 3(Suppl 1):A1 (29 May 2001) |
|
N Bizouarne, P Squiban, B Acres, JM Balloul, MA Ohresser, R Figlin, A Belldegrun, R Herrman, C Rochlitz Breast Cancer Res 2001, 3(Suppl 1):A10 (29 May 2001) |
|
M Blazar, V Cirulli, F Prins, SV Litvinov Breast Cancer Res 2001, 3(Suppl 1):A11 (29 May 2001) |
|
Transcriptional regulation of apoptosis in mouse mammary gland MP Boland, EA Kritikou, RS Chapman, JL Heeley, RWE Clarkson, CJ Watson Breast Cancer Res 2001, 3(Suppl 1):A12 (29 May 2001) |
|
Association of the Epstein-Barr virus with breast cancer: M Bonnet-Duqeynoy, H Arbach, K Takada, I Joab Breast Cancer Res 2001, 3(Suppl 1):A13 (29 May 2001) |
|
Bovine leukemia virus in human breast tissues GC Buehring, KY Choi, HM Jensen Breast Cancer Res 2001, 3(Suppl 1):A14 (29 May 2001) |
|
Restored expression of Fhit protein in Fhit-minus breast cancer cells M Campiglio, C Olgiati, P Aiello, CM Croce, S Ménard Breast Cancer Res 2001, 3(Suppl 1):A15 (29 May 2001) |
|
P Casalini, S Ménard, A Balsari, E Tagliabue, M Campiglio, R Bufalino, N Cascinelli Breast Cancer Res 2001, 3(Suppl 1):A16 (29 May 2001) |
|
Prevention of thymic atrophy in mammary tumor bearers by IFN-gamma V Charyulu, B Adkins, D Lobo, DM Lopez Breast Cancer Res 2001, 3(Suppl 1):A17 (29 May 2001) |
|
Immunotoxins: experimental design P Dall, W Wels Breast Cancer Res 2001, 3(Suppl 1):A18 (29 May 2001) |
|
L Delle Chiaie, S Schindelmann, I Heinich, V Heilmann, G Helms, R Terinde Breast Cancer Res 2001, 3(Suppl 1):A19 (29 May 2001) |
|
R Agresti, E Tagliabue, C Ghirelli, D Morelli, R Giovanazzi, G Somenzi, M Campiglio, M Greco, A Balsari, S Menard Breast Cancer Res 2001, 3(Suppl 1):A2 (29 May 2001) |
|
P Devilee Breast Cancer Res 2001, 3(Suppl 1):A20 (29 May 2001) |
|
M Di Benedetto, D Briane, O Oudar, O Sainte Catherine, J Jozefonvicz, M Kraemer, M Crépin Breast Cancer Res 2001, 3(Suppl 1):A21 (29 May 2001) |
|
S Djahansouzi, D Niederacher, B Hanstein, P Dall, HG Bender Breast Cancer Res 2001, 3(Suppl 1):A22 (29 May 2001) |
|
Prognosis and treatment of locally recurrent breast cancer J Dunst Breast Cancer Res 2001, 3(Suppl 1):A23 (29 May 2001) |
|
Telomerase activity and bcl2 expression in human breast cancer AE Elkak, K Kirkpatrick, L Mears, C Wells, M Ghilchick, K Mokbel Breast Cancer Res 2001, 3(Suppl 1):A24 (29 May 2001) |
|
T Fu, L Herbert, I Keydar, DM Lopez Breast Cancer Res 2001, 3(Suppl 1):A25 (29 May 2001) |
|
I Gaemers, H Volders, J Hilkens Breast Cancer Res 2001, 3(Suppl 1):A26 (29 May 2001) |
|
M Golan, A Hizi, I Keydar, I Tsarfaty] Breast Cancer Res 2001, 3(Suppl 1):A27 (29 May 2001) |
|
Estrogen receptor transcription and transactivation: Antitumor potential of bisphosphonates JR Green Breast Cancer Res 2001, 3(Suppl 1):A28 (29 May 2001) |
|
B Hanstein, T Flötotto, D Luke, D Niederacher, HG Bender Breast Cancer Res 2001, 3(Suppl 1):A29 (29 May 2001) |
|
M Amari, T Moriya, Y Harada, T Ishida, K Ohnuki, N Ohuchi Breast Cancer Res 2001, 3(Suppl 1):A3 (29 May 2001) |
|
KA Hartmann, JJ Feldmeier, G Schmitt, UM Carl Breast Cancer Res 2001, 3(Suppl 1):A30 (29 May 2001) |
|
Sentinel lymph node biopsies in breast cancer A Hess, MO Flüβ, C Nestle-Krämling, HG Bender, P Dall Breast Cancer Res 2001, 3(Suppl 1):A31 (29 May 2001) |
|
Organochlorines and breast cancer: effect of exposure to dieldrin on risk and survival AP Høyer, T Jørgensen, AP Grandjean Breast Cancer Res 2001, 3(Suppl 1):A32 (29 May 2001) |
|
K Huebner, B Turner, WW Hauck, N Popescu Breast Cancer Res 2001, 3(Suppl 1):A33 (29 May 2001) |
|
Estrogen receptor transcription and transactivation: ErbB family of receptors in breast cancer NE Hynes, A Motoyama, HA Lane Breast Cancer Res 2001, 3(Suppl 1):A34 (29 May 2001) |
|
CM Jäger, A Müller, V Heilmann, R Grundmann, R Kreienberg Breast Cancer Res 2001, 3(Suppl 1):A35 (29 May 2001) |
|
Cloning of novel mammary tumor progression and metastasis genes M Kimm, M Boer, I Gaemers, J Hilkens Breast Cancer Res 2001, 3(Suppl 1):A36 (29 May 2001) |
|
K Kirkpatrick, W Ogunkolade, AE Elkak, S Bustin, P Jenkins, M Ghilchick, K Mokbel Breast Cancer Res 2001, 3(Suppl 1):A37 (29 May 2001) |
|
Acidification-induced sensitization to thermoradiotherapy in breast cancer DB Leeper, LT Komarnicky Breast Cancer Res 2001, 3(Suppl 1):A38 (29 May 2001) |
|
S Malherbe, M Bérard, M Di Benedetto, N Peyri, M Crépin, C Legrand, MX Wei Breast Cancer Res 2001, 3(Suppl 1):A39 (29 May 2001) |
|
Phagocytic activity of monocytes in patients with breast cancer at different clinical stages NN Arsenijevic, D Baskic, LD Acimovic Breast Cancer Res 2001, 3(Suppl 1):A4 (29 May 2001) |
|
Structural features for peptides binding the class I molecules I McKenzie, V Apostolopoulos, Y Mu, IA Wilson Breast Cancer Res 2001, 3(Suppl 1):A40 (29 May 2001) |
|
The standardized mistletoe preparation Lektinol has antitumoral potencies U Mengs, A Burger, D Wetzel, K Weber, HH Fiebig Breast Cancer Res 2001, 3(Suppl 1):A41 (29 May 2001) |
|
High-risk breast cancer patients: comparison of lymphocyte phenotypes and function S Mohrmann, A Oletzki, A Karaoglu, U Nitz, U Koldovsky Breast Cancer Res 2001, 3(Suppl 1):A42 (29 May 2001) |
|
A Mostafa, AE Elkak, JCC Hu, K Kirkpatrick, C Wells, R Carpenter, K Mokbel Breast Cancer Res 2001, 3(Suppl 1):A43 (29 May 2001) |
|
U Nitz, S Mohrmann, G Schütt, A Zander, N Kröger, M Frick, HG Bender, on behalf of the West German Study Group (WSG), Düsseldorf, Germany Breast Cancer Res 2001, 3(Suppl 1):A44 (29 May 2001) |
|
IP Nyamagana Butera, S Hadiy, G Leclercq Breast Cancer Res 2001, 3(Suppl 1):A45 (29 May 2001) |
|
MMP-9 production by T cells from mammary tumor bearers is upregulated by tumor-derived VEGF JL Owen, Z Gunja-Smith, DM Lopez Breast Cancer Res 2001, 3(Suppl 1):A46 (29 May 2001) |
|
A retrovirus similar to MMTV associated with human breast cancer BG-T Pogo Breast Cancer Res 2001, 3(Suppl 1):A47 (29 May 2001) |
|
SA Price-Schiavi, V Ramsauer, X Zhu, KL Carraway Breast Cancer Res 2001, 3(Suppl 1):A48 (29 May 2001) |
|
P Ravazoula, E Likaki-Karatza, FA Mpadra, MV Karamouzis, P Aroukatos, E Tzorakoeleptherakis, HP Kalofonos Breast Cancer Res 2001, 3(Suppl 1):A49 (29 May 2001) |
|
The CC chemokine RANTES as a potential contributor to breast cancer progression E Azenshtein, G Luboshits, S Shina, E Neumark, N Vigler, S Chaitchik, I Keydar, A Ben-Baruch Breast Cancer Res 2001, 3(Suppl 1):A5 (29 May 2001) |
|
S Regele, FD Vogel, IB Runnebaum, R Kreienberg Breast Cancer Res 2001, 3(Suppl 1):A50 (29 May 2001) |
|
Whole-body hyperthermia in the treatment of breast cancer E Rethfeldt, M Becker, P Koldovsky Breast Cancer Res 2001, 3(Suppl 1):A51 (29 May 2001) |
|
K Rhiem, M Münch, R Kreutzfeld, P Decker, OD Wiestler, T Bauknecht, RK Schmutzler Breast Cancer Res 2001, 3(Suppl 1):A52 (29 May 2001) |
|
Role of stromelysin-3 in mammary tumor progression MC Rio Breast Cancer Res 2001, 3(Suppl 1):A53 (29 May 2001) |
|
High-dose chemotherapy in breast cancer: Dutch randomized studies S Rodenhuis, H van Tinteren, EGE de Vries Breast Cancer Res 2001, 3(Suppl 1):A54 (29 May 2001) |
|
Novel liposomal vectors for an enhanced gene transfer G Röder, JB Prisack, O Keil, D Niederacher, HG Bender, P Dall Breast Cancer Res 2001, 3(Suppl 1):A55 (29 May 2001) |
|
Pathway pathology: the wnt and erbB mammary tumors A Rosner, RD Cardiff Breast Cancer Res 2001, 3(Suppl 1):A56 (29 May 2001) |
|
CD31 expression by cells of extensive ductal A Sapino, L Righi, P Cassoni, M Bongiovanni, S Deaglio, F Malavasi, G Bussolati Breast Cancer Res 2001, 3(Suppl 1):A57 (29 May 2001) |
|
Neuroendocrine breast carcinomas of aged women may express apocrine differentiation markers A Sapino, P Cassoni, L Righi, M Papotti, P Gugliotta, G Bussolati Breast Cancer Res 2001, 3(Suppl 1):A58 (29 May 2001) |
|
Constitutional genomic instability of 9p23-24 in L Savelyeva, M Schwab Breast Cancer Res 2001, 3(Suppl 1):A59 (29 May 2001) |
|
The relevance of translational research for radiotherapy in breast cancer H Bartelink Breast Cancer Res 2001, 3(Suppl 1):A6 (29 May 2001) |
|
Heterocyclic amines (HCAS) and risk of breast cancer R Sinha, EG Snyderwine Breast Cancer Res 2001, 3(Suppl 1):A60 (29 May 2001) |
|
C Streuli, A Gilmore, P Wang, K Green, A Valentijn Breast Cancer Res 2001, 3(Suppl 1):A61 (29 May 2001) |
|
Normo- and hyperbaric oxygenation of tumors: from bench to bedside O Thews Breast Cancer Res 2001, 3(Suppl 1):A62 (29 May 2001) |
|
Serological Her2/neu-determination in patients receiving Herceptin® A Thomas, M Hoopmann, T Schöndorf, R Neumann, P Mallmann, U-J Göhring, CM Kurbacher, C Eisberg, T Tanasale, M Warm Breast Cancer Res 2001, 3(Suppl 1):A63 (29 May 2001) |
|
Downregulation of macrophage IL-12 production by tumor-derived IL-11 M Torroella, DM Lopez Breast Cancer Res 2001, 3(Suppl 1):A64 (29 May 2001) |
|
A Venkitaraman Breast Cancer Res 2001, 3(Suppl 1):A65 (29 May 2001) |
|
Herceptin clinical trials: past, present and future CL Vogel Breast Cancer Res 2001, 3(Suppl 1):A66 (29 May 2001) |
|
Z Vujaskovic, I Batinic-Haberle, I Spasojevic, I Fridovich, TV Samulski, MW Dewhirst, MS Anscher Breast Cancer Res 2001, 3(Suppl 1):A67 (29 May 2001) |
|
Ultrasound-guided pO2 measurement in breast cancer patients before and after hyperthermia treatment Z Vujaskovic, E Rosen, K Blackwell, EL Jones, LP Prosnitz, TW Samulski, MW Dewhirst Breast Cancer Res 2001, 3(Suppl 1):A68 (29 May 2001) |
|
Haplotype analysis in German families with recurrent B Wappenschmidt, A Golla, A Kempe, A Meindl, RK Schmutzler, and the German Breast Cancer Consortium Breast Cancer Res 2001, 3(Suppl 1):A69 (29 May 2001) |
|
Monocyte phagocytic function in patients with breast cancer during therapy D Baskic, NN Arsenijevic, LD Acimovic Breast Cancer Res 2001, 3(Suppl 1):A7 (29 May 2001) |
|
RB Weiss, CA Hudis, RA Beveridge Breast Cancer Res 2001, 3(Suppl 1):A70 (29 May 2001) |
|
J Wesseling, A Maas, P Hageman, J Storm, M van der Valk, J Hilkens Breast Cancer Res 2001, 3(Suppl 1):A71 (29 May 2001) |
|
D Wetzel, A Gromöller, U Elsässer-Beile Breast Cancer Res 2001, 3(Suppl 1):A72 (29 May 2001) |
|
JM Wood Breast Cancer Res 2001, 3(Suppl 1):A73 (29 May 2001) |
|
The mechanism of tamoxifen in breast cancer prevention F Yu, W Bender Breast Cancer Res 2001, 3(Suppl 1):A74 (29 May 2001) |
|
CD95 ligand expression in dedifferentiated breast cancer C Moers, M Müschen, MW Beckmann, P Mallmann Breast Cancer Res 2001, 3(Suppl 1):A75 (29 May 2001) |
|
CD95 ligand expression mediates immune escape in breast cancer C Moers, M Müschen, MW Beckmann, P Mallmann Breast Cancer Res 2001, 3(Suppl 1):A76 (29 May 2001) |
|
C Moers, M Müschen, MW Beckmann, P Mallmann Breast Cancer Res 2001, 3(Suppl 1):A77 (29 May 2001) |
|
T Bauernhofer, U Friebe-Hoffmann, T Hoffmann, G Dworacki, B Vonderhaar, TL Whiteside Breast Cancer Res 2001, 3(Suppl 1):A8 (29 May 2001) |
|
B Betz, D Larbig, TO Goecke, C Nestle-Krämling, HG Bender, D Niederacher Breast Cancer Res 2001, 3(Suppl 1):A9 (29 May 2001) |